Global Immunoassay Market Research Report

Immunoassay accounted for 26% share of the IVD market in 2013. The recent technological development focuses more on detecting one or several proteins in a patient’s blood or serum. The growth of the immunoassays market will primarily be dependent on the development of novel assays in prime areas, such as cardiology, oncology, and various autoimmune diseases, as these novel assays will help companies gain a competitive edge. The rising automation trend is a major driver for the growth of the immunoassay market as it helps reduce the cost of labor, which accounts for around 50% of the total cost of a test.

The Centers for Medicare & Medicaid Services (CMS) has estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the same period. Similarly, in emerging countries, the growing awareness and the increasing middle-class population, with more disposable incomes to spend on healthcare, will be the major driving factors for the growth of this market.

The report analyzes the market by two segments, namely, immunoassay reagents and immunoassay instruments. These two segments experienced a positive growth till 2013, with a market value of $12.5 billion, comprising $10.59 billion for immunoassay reagents and $1.97 billion for immunoassay instruments, with the overall market projected to grow at a CAGR of 8.5% during the forecast period.

The Americas commanded the largest share of 42% of the immunoassay market at an estimated $5,248.2 million in 2013 and the region is expected to reach $7,563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. Europe holds the second largest market position. From the European region, Germany commanded the largest share of 20% of the immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1,066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The Asian immunoassay market is growing in double digits and will continue to grow in future. China commanded the largest share 53% of the immunoassay market at an estimated $626.0 million in 2013 and is expected to reach $,1309.0 million by 2018, at a CAGR of 16.7% from 2013 to 2018.

The report also provides an extensive competitive landscaping of the leading companies operating in immunoassay market. The major players of the immunoassay market are Siemens (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), and bioMerieux SA (France). The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies in immunoassay market have been detailed in this report.

Customization Options:

Along with market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:

Opportunity Analysis:

The unmet needs, revenue pockets, and potential areas for the expansion of immunoassay market

A comprehensive review of the key component providers, analyzers, and test kit providers in the immunoassay market

Current and Emerging Products:

An analysis of the current and emerging immunoassay and immunodiagnostic tests

A review of current instrumentation technologies in immunoassay

Pricing Trends:

Pricing trend of immunoassay tests

Product Analysis

Usage pattern (in-depth trend analysis) of products (segment-wise)

Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels

End-user adoption rate analysis of the products (segment-wise and country-wise)

A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs

An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

Alternative Products: Impact analysis

MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure)

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

Comments :

Reports Interested in :Global Immunoassay Market Research Report

* Enter the text from the image to the text box :

Custom Market Research Services

We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.

Enzyme Immunoassays (EIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. Germany commanded the largest share of the European enzyme immunoassays market. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market. The report “Global Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. FIA gives the same sensitivity as radioimmunoassay (RIA) and enzyme immunoassays (EIA), but at lower costs because the fluorescent dyes are available at lower prices when compared to enzymes and radioisotopes. The report “Global Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Chemiluminescence Immunoassays (CLIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas Chemiluminescence immunoassays (CLIA) market, Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market, Japan commanded the largest share of the Asia-Pacific Chemiluminescence immunoassays (CLIA) market. The report “Global Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Radioimmunoassays (RIA)
Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. The report “Global Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Europe Immunoassay
Europe holds second largest market position in Global Immunoassay Market. Germany commanded the largest share 20% of the European immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The report “European Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.

Upcoming

North America Immunoassay
The Americas commanded the largest share 42% of the Global Immunoassay market at an estimated $5248.2 million in 2013 and are expected to reach $7563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. The report “North American Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.

Upcoming

Asia Immunoassay
Asian immunoassay market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of the Asian immunoassay market at an estimated $626.0 million in 2013 and is expected to reach $1309.0 million by 2018, at a CAGR of 16.7% from 2013 to 2018. The report “Asian Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.

Upcoming

North America Radioimmunoassays (RIA)
The report “North American Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013.

Upcoming

Asia-Pacific Radioimmunoassays (RIA)
Radioimmunoassay accounted for about one-third of the share of the overall immunoassays market in 2013. The report “Asia-Pacific Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Europe Radioimmunoassays (RIA)
Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. The report “European Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Europe Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “European Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Asia Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “Asian Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

North America Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “North American Fluorescence immunoassays (FIA) Market forecast for 2018“ analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

North America Enzyme Immunoassays (EIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. The report “North American Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Europe Enzyme Immunoassays (EIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Germany commanded the largest share of the European enzyme immunoassays market. The report “European Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Asia Enzyme Immunoassays (EIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market. The report “Asian Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Asia Chemiluminescence Immunoassays (CLIA)
Japan commanded the largest share of the Asia-Pacific Chemiluminescence immunoassays (CLIA) market. The report “Asian Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. The report also provides an extensive competitive landscaping of companies operating in this market.

Upcoming

North America Chemiluminescence Immunoassays (CLIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the North American Chemiluminescence immunoassays (CLIA) market. The report “North American Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.

Upcoming

Europe Chemiluminescence Immunoassays (CLIA)
The report “European Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market. The report also provides an extensive competitive landscaping of companies operating in this market. The major vendors in this market are Ortho Clinical Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), and bioMérieux (France).